Abstract
Summary
Changes in blood flow distribution were studied in the rat following administration of the peptide SQ 20,881, a known inhibitor of angiotensin I converting enzyme and a potentiator of bradykinin activity. Administration of the inhibitor resulted in redistribution of blood flow toward the kidney. The possible relation to effects of angiotensin II and bradykinin on renal function are discussed.
Get full access to this article
View all access options for this article.